Database : HANSEN
Search on : RIFAMICINAS/FARMACOL [Subject descriptor]
References found : 4 [refine]
Displaying: 1 .. 4   in format [Detailed]

page 1 de 1

  1 / 4 HANSEN  
              next record last record
select
to print
Id:13464
Author:Pattyn, S. R; Saerens, E. J
Title:Activity of three new rifamycin derivates on the experimental infection by Mycobacterium leprae ..-
Source:s.l; s.n; 1977. 5 p. tab.
Abstract:Three new rifamycin derivates characterized by longer lasting were tested M. leprae in the mouse model. Their minimal effective dose is slightly to moderately lower than that of rifampicin. Intervals of administration can however not be increased over once every 2 weeks. On a weght basis one of the drugs is 8 times more potent than rifampicin.(AU).
Descriptors:HANSENIASE/quimioter
RIFAMICINAS/farmacol
Limits:ESTUDO COMPARATIVO
ANIMAL
CAMUNDONGOS
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 01454/s


  2 / 4 HANSEN  
              first record previous record next record last record
select
to print
Id:13276
Author:Sanfilippo, A; Della Bruna, C; Marsili, L; Morvillo, E; Pasqualucci, C. R; Schioppacassi, G; Ungheri, D
Title:Biological activity of a new class of rifamycins. Spiro-piperidyl-rifamycins ..-
Source:s.l; s.n; Oct. 1980. 6 p. tab.
Abstract:The biological properties of spiro-piperidyl-rifamycins, a new class of rifamycin antibiotics, are described. In these derivatives the positions 3 and 4 have been incorporated into an imidazolyl ring bearing a spiro-piperidyl group N substituted with linear and branched aliphatic chains. The in vitro antibacterial activity against Staphylococcus aureus and Mycobacterium tuberculosis increases with the number of the carbon atoms in the linera side chain, whereas the inhibitory effect on Escherichia coli is lowered. The antibacterial activity is only marginally affected by branching of the side chain. In vivo (experimental infections of mice) the optimal therapeutic activity against M. tuberculosis is shown by compounds bearing 3 approximately 5 carbon atoms as a linear or branched side chain; in comparison with rifampicin, the potency of these derivatives is 2 approximately 3 times higher. The finding is in a good agreement with the exceptional tissue tropism, which seems to be a favourable property of this group of derivatives.
Descriptors:CINETICA
RIFABUTINA
RIFAMICINAS/metab
RIFAMICINAS/farmacol
DISTRIBUICAO TECIDUAL
INFECCOES BACTERIANAS/quimioter
BACTERIAS/ef drogas
Limits:ANIMAL
FEMININO
CAMUNDONGOS
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00687/s


  3 / 4 HANSEN  
              first record previous record next record last record
select
to print
Id:9829
Author:Lal, Rup; Lal, Sukanya
Title:Recent trends in rifamycin research ..-
Source:s.l; s.n; 1994. 6 p. ilus.
Descriptors:HANSENIASE
MYCOBACTERIUM AVIUM
MYCOBACTERIUM LEPRAE
MYCOBACTERIUM TUBERCULOSIS
DNA POLIMERASE DIRIGIDO POR RNA
RIFAMICINAS
RIFAMICINAS
RIFAMICINAS
TUBERCULOSE
Location:BR191.1; 06719/s


  4 / 4 HANSEN  
              first record previous record
select
to print
Id:6868
Author:Fernandes, G.
Title:DDS X Rifampicina: comparacao da atividade terapeutica das duas drogas em gemeos hansenicos.
Descriptors:HANSENIASE
HANSENIASE
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
HANSENIASE TUBERCULOIDE
HANSENIASE TUBERCULOIDE
SULFONAS
 SULFONAS
 SULFONAS
 SULFONAS
 SULFONAS
 RIFAMICINAS
 RIFAMICINAS
 RIFAMICINAS
 RIFAMICINAS
 RIFAMICINAS
 RIFAMICINAS
 RIFAMICINAS



page 1 de 1
   


Refine the search
  Database : HANSEN Advanced form   
Search for : Free form   

    Search in field  
1  
2
3
 
           



Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO
Latin American and Caribbean Center on Health Sciences Information